ACM Global Laboratories

ACM Global Laboratories operates across four continents, delivering central laboratory services, bioanalysis, and toxicology to sponsors running clinical trials at every stage of development. With facilities in Rochester (NY), York (UK), Singapore, and Mumbai, the organisation functions as a single integrated laboratory network rather than a collection of regional outposts, giving study teams a consistent standard of science regardless of trial geography.

Central Lab and Bioanalytical Capabilities

The central lab division handles routine safety testing, biomarker testing, flow cytometry, radiopharmaceutical services, and pathology, alongside the full spectrum of clinical trial testing. Sponsors with urgent timelines can access dedicated rescue and expedite study pathways, reducing the risk that slow laboratory turnaround becomes the critical path on a programme. Sample logistics are supported by customised collection kits and advanced sample tracking, which simplifies the co-ordination burden for site staff and CRO project managers alike.

The bioanalytical services portfolio covers large molecule bioanalysis, advanced pharmacokinetic bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, and work on novel drug delivery systems. Specialist capability extends to nicotine research and cannabinoid testing, areas that require particular regulatory sensitivity. COVID-19 research studies are also accommodated within the central lab offering.

Toxicology and Workplace Testing

The toxicology division provides drug monitoring, workplace testing, and reference laboratory testing, serving both clinical development programmes and occupational health requirements. This breadth makes ACM Global Laboratories relevant to pharmaceutical, biotech and corporate clients whose needs span the regulated and non-regulated sectors.

Client-facing resources include a self-service portal, the ACM QuikReport tool, and LabStar, a platform that supports site training and sample management. The combination of these digital tools with a global physical footprint positions the organisation well for decentralised and hybrid trial designs that are now common across the industry. ACM marks fifty years of operation, a milestone that underscores the depth of institutional experience behind its service model.

Further information is available at acmgloballab.com.